Centaurus Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-40,255
Closed -$36K 952
2022
Q4
$36K Hold
40,255
﹤0.01% 825
2022
Q3
$63K Hold
40,255
0.01% 838
2022
Q2
$81K Hold
40,255
0.01% 811
2022
Q1
$94K Buy
40,255
+2,700
+7% +$8.42K 0.01% 873
2021
Q4
$175K Buy
37,555
+8,020
+27% +$49.8K 0.01% 714
2021
Q3
$225K Buy
29,535
+4,100
+16% +$34.8K 0.02% 619
2021
Q2
$246K Hold
25,435
0.02% 620
2021
Q1
$210K Hold
25,435
0.02% 588
2020
Q4
$174K Hold
25,435
0.02% 589
2020
Q3
$284K Sell
25,435
-2,840
-10% -$26K 0.04% 382
2020
Q2
$178K Buy
28,275
+275
+1% +$1.05K 0.03% 457
2020
Q1
$52K Buy
28,000
+5,000
+22% +$14.4K 0.01% 510
2019
Q4
$78K Buy
23,000
+5,000
+28% +$11.9K 0.01% 620
2019
Q3
$39K Hold
18,000
0.01% 443
2019
Q2
$48K Buy
18,000
+17,914
+20,830% +$64.5K 0.01% 589
2019
Q1
$18K Buy
+86
New +$226 0.11% 170
2018
Q3
Sell
-3,000
Closed -$22K 2199
2018
Q2
$22K Buy
+3,000
New +$20.4K ﹤0.01% 1241

Other funds holding SRNE